Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Chalazion × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 45 Stomach Neoplasms 27 Pancreatic Neoplasms 16 Rectal Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 9 Neoplasms 9 Neoplasm Metastasis 9 Head and Neck Neoplasms 7 Esophageal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 7 Adenocarcinoma Of Esophagus 7 Adenocarcinoma 7 Colonic Neoplasms 6 Ovarian Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Biliary Tract Neoplasms 5 Advanced Solid Tumors 5 Peritoneal Neoplasms 4 Nasopharyngeal Carcinoma 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Locally Recurrent Rectal Cancer 2 Locally Advanced Rectal Cancer 2 Endometrial Neoplasms 2

Interventions

Triamcinolone Acetonide 1 Triamcinolone 1 Fluorouracil 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡